Overview
Ingo represents and advises clients in merger control, cartel and abuse of dominance proceedings before the European Commission, the Bundeskartellamt (the Federal Cartel Office) and courts, and he advises clients in foreign investment proceedings as well as on competition law compliance matters.
He has particular experience in the financial services, pharmaceuticals, network industries, IT/software, consumer goods, chemical and petrochemical industries, as well as in the private equity business.
Ingo has been awarded with the Antitrust Rising Star of the Year 2024 by Legal500 and is listed in Who’s Who Legal as Future Leader in Competition where a client described him as “one of the best competition law experts I have ever met”.
He’s also ranked as “Best Lawyer” for Antitrust and Competition Law by Handelsblatt 2024.
Work Highlights
Ingo has advised and represented clients in many major competition cases. These include:
- Bayer: advising on the US$7,6bn sale of its animal health business to Elanco, the acquisition of the biotech company KaNDy Therapeutics Ltd. and the carve-out of Covestro.
- Nestlé: advising on the acquisition of Aimmune Therapeutics, Inc. by way of a public takeover offer and the acquisition of a shareholding in veterinary services provider IVC Group.
- Asklepios: advising on the takeover offer for Rhön Klinikum.
- LetterOne: advising on acquisitions in the oil and gas business, in particular RWE DEA and the US2$1bn combination of DEA with Wintershall.
- E.ON: advising on the far-reaching asset swap with RWE, the sale of its 46.6% stake in Uniper to Fortum and one of the few “hostile” takeover bids in Germany.
- Deutsche Börse: advising on several transactions, including the proposed merger with London Stock Exchange, the proposed merger with New York Stock Exchange, the launch of FundsDLT, a blockchain-based technology platform for the investment fund industry, the expansion of the participation in Tradegate AG Wertpapierhandelsbank and the acquisition of electronic FX trading platform 360T.
- Alcon, Bayer, BayWa, INEOS, Deutsche Börse, SC Johnson and Novartis: advising on competition law compliance in distribution cases.
Admissions